Personalized Nutrition in Young Adults: The Ability of Genetic Information to Motivate Changes in Omega-3 Consumption
1 other identifier
interventional
57
0 countries
N/A
Brief Summary
There are many health benefits associated with the consumption of omega-3 dietary fats. Omega-3 fats, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), can be found in marine food products such as fatty fish, in fortified products such as eggs and milk, or in dietary supplements such as fish oil. Despite numerous health benefits, it is well documented that most people in Western society are not meeting the recommended daily amounts of EPA and DHA omega-3 fats. The overall objective of this study is to examine whether providing young adults (18-25 years) with personal genetic information changes behavior with regards to omega-3 fat consumption. In order to achieve this objective, study participants will be divided into two groups: 1. Genetic and 2. Non-Genetic. The Genetic Group will be provided with their personalized information regarding a common gene variant in addition to general information regarding the health benefits of omega-3 fats, while the Non-Genetic Group will only receive the general information. Primary outcomes studied will include dietary habits and secondary outcomes include blood markers of cardiometabolic health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2015
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 6, 2016
CompletedFirst Posted
Study publicly available on registry
July 12, 2016
CompletedResults Posted
Study results publicly available
January 9, 2018
CompletedFebruary 5, 2018
January 1, 2018
7 months
July 6, 2016
December 11, 2017
January 8, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Omega-3 Dietary Intake
Omega-3 fat intake was assessed using food frequency questionnaires. The Canadian Nutrient File (version 2015) was used to assess the amount of EPA and DHA in whole foods (e.g., fish, eggs, poultry). Data corresponds to EPA + DHA (mg /day).
Baseline and 12 weeks
Secondary Outcomes (2)
Change in Blood Triglycerides (Physiological Parameter)
baseline and 12 weeks
Change in Omega-3 Index in Blood (Physiological Parameter)
baseline and 12 weeks
Study Arms (2)
Non-genetic Group
PLACEBO COMPARATORGeneral Nutrition related to Omega-3 fats: Individuals in this group will be provided with only general nutrition information related to omega-3 fats and health.
Genetic Group
EXPERIMENTALGenetic information and Omega-3 fat intake: Individuals in this group will be provided with general nutrition information related to omega-3 fats and health, as well as their personal genetic information for a common gene variant related to omega-3 fatty acid metabolism.
Interventions
Only the Genetic group will receive their personal genetic information prior to beginning the 3-month study.
Both the Genetic and Non-Genetic groups will receive general nutrition information about omega-3 fats.
Eligibility Criteria
You may qualify if:
- Between the ages of 18-25 years
You may not qualify if:
- Younger than 18 years
- Older than 25 years
- Allergic to fish and/or shellfish
- If the participants are currently consuming high amounts of omega-3 food products
- Unable to get to the University of Guelph for study visits (lack of transportation, or lives too far away)
- Anticipating a significant change in lifestyle (moving houses, joining the gym, participating in elite athletic activities)
- Not comfortable giving blood samples
- Taking medication which modifies or changes blood lipid levels
- Expecting to become pregnant, pregnant or lactating
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (6)
Tur JA, Bibiloni MM, Sureda A, Pons A. Dietary sources of omega 3 fatty acids: public health risks and benefits. Br J Nutr. 2012 Jun;107 Suppl 2:S23-52. doi: 10.1017/S0007114512001456.
PMID: 22591897BACKGROUNDMicha R, Khatibzadeh S, Shi P, Fahimi S, Lim S, Andrews KG, Engell RE, Powles J, Ezzati M, Mozaffarian D; Global Burden of Diseases Nutrition and Chronic Diseases Expert Group NutriCoDE. Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ. 2014 Apr 15;348:g2272. doi: 10.1136/bmj.g2272.
PMID: 24736206BACKGROUNDBeasley LJ, Hackett AF, Maxwell SM. The dietary and health behaviour of young people aged 18-25 years living independently or in the family home in Liverpool, UK. International Journal of Consumer Studies 28(4): 355-363, 2004.
BACKGROUNDDemory-Luce D, Morales M, Nicklas T, Baranowski T, Zakeri I, Berenson G. Changes in food group consumption patterns from childhood to young adulthood: the Bogalusa Heart Study. J Am Diet Assoc. 2004 Nov;104(11):1684-91. doi: 10.1016/j.jada.2004.07.026.
PMID: 15499355BACKGROUNDMcBride CM, Koehly LM, Sanderson SC, Kaphingst KA. The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annu Rev Public Health. 2010;31:89-103. doi: 10.1146/annurev.publhealth.012809.103532.
PMID: 20070198BACKGROUNDRoke K, Walton K, Klingel SL, Harnett A, Subedi S, Haines J, Mutch DM. Evaluating Changes in Omega-3 Fatty Acid Intake after Receiving Personal FADS1 Genetic Information: A Randomized Nutrigenetic Intervention. Nutrients. 2017 Mar 6;9(3):240. doi: 10.3390/nu9030240.
PMID: 28272299RESULT
Results Point of Contact
- Title
- Dr. David M Mutch
- Organization
- University of Guelph
Study Officials
- PRINCIPAL INVESTIGATOR
David M Mutch, PhD
University of Guelph
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. David Mutch, PhD
Study Record Dates
First Submitted
July 6, 2016
First Posted
July 12, 2016
Study Start
August 1, 2015
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
February 5, 2018
Results First Posted
January 9, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share